| Olaratumab studied in …STUDIED_INderived20 of 20show fewer |
|---|
| → studied in | NCT02451943Phase 3 · completed A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03994627approved for marketing Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126591Phase 1 · completed A Study of Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03086369Phase 1/Phase 2 · completed A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer · 20 trials list this drug (0 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02659020Phase 1/Phase 2 · completed A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02377752Phase 1 · completed A Study of Olaratumab in Japanese Participants With Advanced Cancer · 20 trials list this drug (0 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03283696Phase 1 · completed A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698227Phase 2 · terminated OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma Patients · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02677116Phase 1 · completed A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer · 20 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02326025Phase 1 · completed A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00913835Phase 2 · completed A Study of Liposomal Doxorubicin With or Without Olaratumab (IMC-3G3) in Platinum-Refractory or Resistant Advanced Ovarian Cancer · 20 trials list this drug (0 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204710Phase 2 · completed A Study of Olaratumab (IMC-3G3) in Prostate Cancer · 20 trials list this drug (0 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02783599Phase 1 · completed A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03437070Phase 1 · withdrawn Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma · 20 trials list this drug (0 active) | — | — | Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00918203Phase 2 · completed A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) · 20 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895180Phase 2 · completed Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme · 20 trials list this drug (0 active) | — | — | Adult Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01185964Phase 1/Phase 2 · completed A Study of Olaratumab in Soft Tissue Sarcoma · 20 trials list this drug (0 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199822Phase 1 · completed Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors · 20 trials list this drug (0 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316263Phase 2 · terminated A Study of Olaratumab (IMC-3G3) in Previously Treated Participants With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors · 20 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00768391Phase 1 · completed Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available · 20 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |